Product:
Single Chamber: The single chamber external pacemakers segment is anticipated to witness significant growth due to the increasing prevalence of bradycardia and the rising adoption of single chamber pacemakers for its treatment.
Dual Chamber: The dual chamber external pacemakers segment is expected to register a steady growth rate owing to the advantages of better synchronization between the chambers and improved patient outcomes in cases of acute myocardial infarction.
Application:
Bradycardia: The bradycardia application segment is projected to dominate the external pacemaker market as bradycardia is a common condition that requires pacemaker therapy for managing slow heart rates.
Acute Myocardial Infarction: The acute myocardial infarction application segment is likely to witness substantial growth due to the increasing incidence of heart attacks and the need for external pacing in emergency situations.
End-user:
Hospitals: The hospitals end-user segment is expected to hold a major share in the external pacemaker market as hospitals are equipped with advanced medical facilities and skilled healthcare professionals for treating cardiac conditions requiring pacemaker therapy.
Ambulatory Surgical Centers: The ambulatory surgical centers end-user segment is anticipated to show significant growth owing to the increasing preference for outpatient procedures and the rising availability of external pacemaker devices in these facilities.
Others: The other end-user segment, including clinics and cardiology centers, is likely to witness steady growth due to the rising awareness about pacemaker therapy and the increasing prevalence of cardiac diseases in the population.